GW Pharmaceuticals Market Cap 2013-2020 | GWPH
GW Pharmaceuticals market cap history and chart from 2013 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. GW Pharmaceuticals market cap as of July 09, 2020 is $3.98B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.977B | $0.311B |
| GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $165.688B | 28.73 |
| Medtronic (MDT) | Ireland | $120.891B | 19.64 |
| Stryker (SYK) | United States | $66.633B | 21.63 |
| Boston Scientific (BSX) | United States | $48.278B | 22.70 |
| Baxter (BAX) | United States | $43.462B | 26.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.008B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.981B | 0.00 |
| Terumo (TRUMY) | Japan | $28.231B | 36.09 |
| ResMed (RMD) | United States | $28.021B | 44.22 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.281B | 15.28 |
| Sunny Optical Technology (SNPTF) | China | $20.840B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.828B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.172B | 64.51 |
| Insulet (PODD) | United States | $13.329B | 1320.56 |
| DiaSorin S.p.A (DSRLF) | Italy | $11.312B | 0.00 |
| Quidel (QDEL) | United States | $10.288B | 80.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $8.773B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.676B | 39.13 |
| Perrigo (PRGO) | Ireland | $7.396B | 13.23 |
| Hill-Rom Holdings (HRC) | United States | $7.394B | 20.84 |
| William Demant Holdings (WILYY) | Denmark | $6.296B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.620B | 0.00 |
| Haemonetics (HAE) | United States | $4.381B | 26.31 |
| Neogen (NEOG) | United States | $4.079B | 69.10 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.923B | 0.00 |
| ICU Medical (ICUI) | United States | $3.761B | 27.44 |
| Agios Pharmaceuticals (AGIO) | United States | $3.676B | 0.00 |
| Envista Holdings (NVST) | United States | $3.138B | 0.00 |
| NuVasive (NUVA) | United States | $2.743B | 22.03 |
| TG Therapeutics (TGTX) | United States | $2.661B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.237B | 38.71 |
| AtriCure (ATRC) | United States | $1.768B | 0.00 |
| MacroGenics (MGNX) | United States | $1.508B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.361B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.333B | 0.00 |
| Aphria (APHA) | Canada | $1.206B | 0.00 |
| Cerus (CERS) | United States | $1.148B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $1.069B | 40.24 |
| Cardiovascular Systems (CSII) | United States | $1.042B | 0.00 |
| Vapotherm (VAPO) | United States | $1.014B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 19.85 |
| PetIQ (PETQ) | United States | $0.961B | 27.75 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.890B | 148.08 |
| OraSure Technologies (OSUR) | United States | $0.860B | 173.13 |
| Zynex (ZYXI) | United States | $0.853B | 85.70 |
| InMode (INMD) | Israel | $0.853B | 18.02 |
| Quanterix (QTRX) | United States | $0.779B | 0.00 |
| Omeros (OMER) | United States | $0.731B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.646B | 46.29 |
| BioLife Solutions (BLFS) | United States | $0.572B | 162.82 |
| VAREX IMAGING (VREX) | United States | $0.571B | 14.18 |
| Lantheus Holdings (LNTH) | United States | $0.571B | 11.49 |
| Surmodics (SRDX) | United States | $0.562B | 67.75 |
| LeMaitre Vascular (LMAT) | United States | $0.521B | 29.67 |
| Owens & Minor (OMI) | United States | $0.466B | 12.33 |
| Viemed Healthcare (VMD) | United States | $0.413B | 36.62 |
| Cytosorbents (CTSO) | United States | $0.368B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.343B | 0.00 |
| HEXO (HEXO) | $0.328B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.302B | 21.90 |
| Organigram Holdings (OGI) | Canada | $0.262B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.224B | 124.11 |
| Female Health (VERU) | United States | $0.209B | 0.00 |
| Chimerix (CMRX) | United States | $0.192B | 0.00 |
| Surface Oncology (SURF) | United States | $0.161B | 0.00 |
| Bovie Medical (APYX) | United States | $0.158B | 0.00 |
| Fonar (FONR) | United States | $0.134B | 11.83 |
| Exagen (XGN) | United States | $0.133B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.122B | 0.00 |
| United Health Products (UEEC) | United States | $0.117B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.114B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.108B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.104B | 0.00 |
| Evolus (EOLS) | United States | $0.102B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.096B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
| Nephros (NEPH) | United States | $0.068B | 0.00 |
| United-Guardian (UG) | United States | $0.066B | 15.32 |
| Capricor Therapeutics (CAPR) | United States | $0.065B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.063B | 0.00 |
| Brainsway (BWAY) | Israel | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.036B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.027B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.017B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
